| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1985PNAS...82.6918P |
| P356 | DOI | 10.1073/PNAS.82.20.6918 |
| P932 | PMC publication ID | 390799 |
| P698 | PubMed publication ID | 3876562 |
| P5875 | ResearchGate publication ID | 19284501 |
| P2093 | author name string | H R Colten | |
| D H Perlmutter | |||
| F S Cole | |||
| D Van Thiel | |||
| R M Kay | |||
| T H Rossing | |||
| P2860 | cites work | Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-Cellulose | Q24563043 |
| Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig | Q24594549 | ||
| Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose | Q24611198 | ||
| Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product | Q24629754 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| An efficient mRNA-dependent translation system from reticulocyte lysates | Q29620557 | ||
| Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function | Q34255957 | ||
| Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency | Q34998276 | ||
| Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ | Q35110189 | ||
| Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex | Q36210362 | ||
| Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism | Q36586617 | ||
| The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes | Q36616491 | ||
| Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages | Q37676803 | ||
| Purification and Partial Characterization of PAS-Positive Inclusion Bodies from the Liver in Alpha1-Antitrypsin Deficiency | Q39312012 | ||
| Characterization of α1-Antitrypsin in the Inclusion Bodies from the Liver in α1-Antitrypsin Deficiency | Q39944491 | ||
| Human plasma proteinase inhibitors | Q40107740 | ||
| Catabolic rate of α1-antitrypsin of Pi type M and Z in man | Q40647354 | ||
| α-1-Antitrypsin: Sequence of the Z variant tryptic peptide | Q40653898 | ||
| Catabolic Rate of α1-Antitrypsin of Pi Types S, and MMalton and of Asialylated M-Protein in Man | Q40682532 | ||
| α 1 -Antitrypsin: The Presence of Excess Mannose in the Z Variant Isolated from Liver | Q40689228 | ||
| Characterization of a Peptide Released during the Reaction of Human β1–Antitrypsin and Bovine β-Chymotrypsin1 | Q40726168 | ||
| Swainsonine treatment accelerates intracellular transport and secretion of glycoproteins in human hepatoma cells | Q44495157 | ||
| Distribution and elimination of exogenous alpha1-antitrypsin | Q47670910 | ||
| α1-Antitrypsin deficiency detection by direct analysis of the mutation in the gene | Q59065004 | ||
| Amino acid substitution Glu→Lys in α1-antitrypsin PiZ | Q66884920 | ||
| Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver | Q70228345 | ||
| Rabbit haemoglobin synthesis in frog cells: the translation of reticulocyte 9 s RNA in frog oocytes | Q70736543 | ||
| Synthesis of alpha 1-anti-trypsin by human monocytes | Q70986544 | ||
| Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin | Q70993758 | ||
| Xenopusoocytes can synthesise but do not secrete the Z variant of human α1-antitrypsin | Q72727790 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6918-6921 | |
| P577 | publication date | 1985-10-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. | |
| P478 | volume | 82 |
| Q64234488 | A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients |
| Q35759026 | A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency |
| Q40922322 | A lymphokine regulates expression of alpha-1-proteinase inhibitor in human monocytes and macrophages |
| Q41513791 | A vesicular intermediate in the transport of hepatoma secretory proteins from the rough endoplasmic reticulum to the Golgi complex |
| Q27932696 | ADD66, a gene involved in the endoplasmic reticulum-associated degradation of alpha-1-antitrypsin-Z in yeast, facilitates proteasome activity and assembly. |
| Q33906055 | Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium |
| Q37118167 | Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency |
| Q24795113 | Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro |
| Q34673798 | Divergent expression of alpha1-protease inhibitor genes in mouse and human |
| Q41017471 | Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency |
| Q35246392 | Emphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exon. |
| Q36994663 | Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals |
| Q36963945 | Human plasma protein N-glycosylation |
| Q35889833 | Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. |
| Q41674444 | Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency. |
| Q37383352 | Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency |
| Q34576820 | Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells |
| Q34567578 | Intracellular traffic of newly synthesized proteins. Current understanding and future prospects |
| Q42938869 | Lipopolysaccharide modulates the expression of alpha 1 proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages |
| Q41018168 | Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis |
| Q36763414 | Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342. |
| Q36712966 | Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele |
| Q72282212 | Molecular mechanism of hepatocellular injury in alpha 1 antitrypsin deficiency |
| Q69908931 | Mott cells: a model to study immunoglobulin secretion |
| Q36847215 | Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene |
| Q49057165 | Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants |
| Q50014672 | Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases |
| Q48590852 | Plasma proteins in health and disease: a scientific symposium to celebrate the career and accomplishments of Harvey R. Colten, M.D. |
| Q38988633 | Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency |
| Q41509050 | Review: alpha 1-antitrypsin deficiency associated liver disease |
| Q34579205 | Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease |
| Q36466323 | The endosomal protein-sorting receptor sortilin has a role in trafficking α-1 antitrypsin |
| Q33929609 | The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes |
| Q55011363 | The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. |
| Q41107326 | Two distinct factors interact with the promoter regions of several liver-specific genes |
| Q90448579 | Types of acute phase reactants and their importance in vaccination |
| Q39749056 | alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage |
| Q36816779 | α 1 ‐antitrypsin deficiency and liver disease |
| Q37643457 | α1-antitrypsin Deficiency: A Misfolded Secretory Protein Variant with Unique Effects on the Endoplasmic Reticulum |
Search more.